# Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy

> **NCT00348530** · PHASE4 · UNKNOWN · sponsor: **Medical University of Silesia** · enrollment: 120 (—)

## Conditions studied

- Systolic Heart Failure
- Myocardial Disease
- Cardiomyopathy

## Interventions

- **DRUG:** Verapamil

## Key facts

- **NCT ID:** NCT00348530
- **Lead sponsor:** Medical University of Silesia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 120 (—)
- **Last updated:** 2006-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348530, "Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00348530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*